Ignite Creation Date:
2024-05-06 @ 8:17 AM
Last Modification Date:
2024-10-26 @ 11:58 AM
Study NCT ID:
NCT02706626
Status:
TERMINATED
Last Update Posted:
2023-01-26
First Post:
2016-03-08
Brief Title:
Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors
Sponsor:
Organization:
Criterium Inc